Alfred-Nobel-Str. 10
Monheim am Rhein 40789
Germany
49 2173 8955 4949
https://apontis-pharma.de
版塊: Healthcare
行業: Drug Manufacturers—Specialty & Generic
全職員工: 134
名稱 | 標題 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Mr. Karlheinz Gast | Chairman of the Management Board & CEO | 450k | 無 | 無 |
Mr. Thomas Milz | Chief Product Officer & Deputy Chairman of Management Board | 354k | 無 | 無 |
Mr. Thomas Zimmermann | Chief Financial Officer | 無 | 無 | 無 |
Mr. Harald Weyand | Head of Marketing | 無 | 無 | 無 |
Dr. Matthias Wendl | Head of Sales | 無 | 無 | 無 |
Ms. Susanne Böhm | Head of HR | 無 | 無 | 無 |
Dr. Olaf Randerath | Head of Medicine | 無 | 無 | 無 |
Dr. Susanne Endreß | Head of QA, Drug Safety & Regulatory Affairs | 無 | 無 | 無 |
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.
截至 無 止,Apontis Pharma AG 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。